Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome

Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis
4 agosto 2017
D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
4 agosto 2017

Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome

Trivalent chromium (1000 microg), as chromium picolinate, given without change in diet or activity level, caused a 38% mean improvement in glucose disposal rate in five obese subjects with polycystic ovary syndrome who were tested with a euglycemic hyperinsulinemic clamp technique. This suggests that chromium picolinate, an over-the-counter dietary product, may be useful as an insulin sensitizer in the treatment of polycystic ovary syndrome.